Partnering and collaborations are essential parts of PEPTONIC medical’s business model. We are dependent on our partners for advancing the development of our pipeline products according to our plans and expectations. Hence, we put a lot of emphasis on partnering activities and on managing our partnerships and alliances.
PEPTONIC medical’s most advanced program – VagiVital™ – for the treatment of vaginal atrophy – is in commercialization phase. This a hormone free medical device product with no active substances. We are seeking partners for registration, commercial launch and distribution in all geographies.
In addition to vaginal atrophy, PEPTONIC medical owns patents relating to the use of oxytocin for a number of medical indications. Please, contact us for more information about these opportunities.
For information about partnering and partnering opportunities, please contact;